Resonant Therapeutics ^Private

Resonant Therapeutics is a cutting-edge organization that specializes in tumor microenvironment research. Their platform enables the rapid discovery of therapeutic targets and high affinity antibodies. By leveraging their insights into the tumor microenvironment and immune system, they can identify targets and therapeutic candidates for various types of cancer. Their pipeline includes candidates with potent anti-tumor activity, particularly in breast and ovarian cancers. These antibodies have the potential to be used as standalone treatments or in combination with emerging immunotherapies.